loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Symbicort

    Menu

    Symbicort

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,439Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20929 / DOSAGE - SUSPENSION;INHALATION - 1MG/2ML

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BUDESONIDE(UNII: Q3OKS62Q6X)
    (BUDESONIDE - UNII:Q3OKS62Q6X)     		BUDESONIDE0.5mg in 2

    Inactive Ingredients

    Ingredient Name
    Cardinal Health
    A-S Medication Solutions
    American Health Packaging
    Cipla USA Inc.
    Exelan Pharmaceuticals, Inc.
    NorthStar RxLLC
    Preferred Pharmaceuticals Inc.
    Teva Pharmaceuticals USA, Inc.
    ANHYDROUS CITRIC ACID(XF417D3PSL)       
    CITRIC ACID MONOHYDRATE(2968PHW8QP) 
    EDETATE DISODIUM(7FLD91C86K)
    POLYSORBATE 80(6OZP39ZG8H)
    SODIUM CHLORIDE(451W47IQ8X)
    SODIUM CITRATE(1Q73Q2JULR)    
    SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)     
    TRISODIUM CITRATE DIHYDRATE(B22547B95K)      
    WATER(059QF0KO0R)